C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
12/2006
12/13/2006	EP1730114A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
12/13/2006	EP1392676B1 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
12/13/2006	CN1878759A Pyridazin-3 (2H) -one derivatives and their use as PDE4 inhibitors
12/13/2006	CN1878756A Sulfonyltetrahydro-3H-benzo(E)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
12/13/2006	CN1289501C Fused heterotricyclic compound, process for preparing compounds and drugs containing the same
12/13/2006	CN1289490C Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
12/13/2006	CN1289466C Pharmaceutical compounds
12/12/2006	US7148226 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
12/12/2006	US7148214 Antihistaminic spiro compounds
12/12/2006	CA2289545C Process for the preparation of 2-[(2-thienyl)-ethylamino]-(2-halogenophenyl)acetamides
12/12/2006	CA2147608C Topoisomerase ii inhibitors and therapeutic uses therefor
12/07/2006	WO2006129623A1 Thienotriazolodiazepine compound and a medicinal use thereof
12/07/2006	WO2006128657A1 Sphingolipids
12/07/2006	WO2006058088A3 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
12/07/2006	US20060276531 Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia
12/07/2006	US20060276497 Novel multicyclic compounds and the use thereof
12/07/2006	US20060276490 Thiopyrimidine and isothiazolopyrimidine Kinase Inhibitors
12/07/2006	US20060276489 Inhibitors of Tubulin Polymerization
12/07/2006	US20060276456 Such as [1,1-biphenyl]-4-yl-(5,11-dihydro-10H-dibenzo[b,e][1,4]diazepin-10-yl)methanone; for treatment of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or hemophilia
12/07/2006	US20060275750 Bioreactive agents
12/07/2006	DE102005025625A1 New benzazecine derivatives are dopamine receptor antagonists useful to treat schizophrenia
12/06/2006	EP1728810A1 2-flouroalkyl-thieno[3,4-b]thiophene derivatives and polymers therefrom
12/06/2006	EP1728794A1 Maleate addition salt of hydropyridine derivatives
12/06/2006	EP1727825A1 Labelling reagents, methods for the synthesis of such reagents and methods for the detection of biological molecules
12/06/2006	CN1875023A Use of thienopyrimidines
12/06/2006	CN1874843A Novel multicomponent oxidation catalyst and process for producing epoxy compound therewith
12/06/2006	CN1872859A Compound of heterocyclic pyridine class
12/06/2006	CN1288137C 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone
12/05/2006	US7145019 Biotinated macromolecules having protein reactive groups that react with functional groups on proteins including sulfhydryl and amine groups, used in the detection and isolation of targets from heterologous mixtures
11/2006
11/30/2006	WO2006125531A2 Thienopyridines
11/30/2006	US20060270729 Agents useful for reducing amylioid precursor protein and treating dementia and methods of use thereof
11/30/2006	US20060270726 Phenyl substituted cyclic derivatives
11/30/2006	US20060270689 Novel Fused Heterocycles and Uses Thereof
11/30/2006	US20060270671 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
11/30/2006	US20060270656 Substituted piperazines of azepines, oxazepines and thiazepines
11/30/2006	CA2609385A1 Thienopyridines
11/30/2006	CA2609004A1 Tetrahydropyridothiophenes for use in the treatment of cancer
11/30/2006	CA2609003A1 Tetrahydropyridothiophenes for use in the treatment of cancer
11/29/2006	EP1725567A1 Spirocyclic cyclohexane derivatives with affinity to the orl-1 receptor
11/29/2006	EP1725529A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain
11/29/2006	EP1648408A4 Azepine derivatives as pharmaceutical agents
11/29/2006	CN1871242A 3-(4-aminophenyl) thienopyrimid-4-one derivatives as MCH R1 antagonists for the treatment of obesity, diabetes, depression and anxiety
11/29/2006	CN1869038A Fluorinated alkyl substituted-thieno[3,4-b]thiophene monomers and polymers therefrom
11/28/2006	US7141578 For treating cancer, cardiovascular, sexual and immune disorders; 3a alpha ,4 beta ,5 alpha ,7 beta ,7a alpha )-4-(Octahydro-5- ethylsulfonamido-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2- (trifluoromethyl)benzonitrile
11/28/2006	CA2379640C Certain alkylene diamine-substituted heterocycles
11/28/2006	CA2305370C Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function
11/23/2006	WO2006124874A2 Inhibitors of b-raf kinase
11/23/2006	WO2006122944A1 Selected tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
11/23/2006	WO2005054234A8 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy
11/23/2006	US20060264636 Salts of clopidogrel and process for preparation
11/23/2006	US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay
11/23/2006	US20060264494 Heterocyclic amide derivatives which process glycogen phorylase inhibitory activity
11/23/2006	US20060264452 Analgesics; immunomodulators and for treatment of drug dependence; for example, 5'-Bromo-17-(cyclopropylmethyl)-6,7-didehydro-3,14-dihydroxy-4,5 alpha -epoxypyrido[2',3':6,7]morphinan
11/23/2006	US20060264429 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
11/23/2006	US20060264420 Tteating cell proliferation disease by modulation of kinesin and treatment of cancer
11/23/2006	DE60202452C5 Pyridazinonaldose reductase inhibitoren Reductase inhibitors Pyridazinonaldose
11/23/2006	CA2606774A1 Selected tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
11/22/2006	EP1724272A1 Chalcogen-containing fused-ring polycyclic organic material and process for producing the same
11/22/2006	EP1724268A1 Compound having tgf-beta inhibitory activity and pharmaceutical composition containing same
11/22/2006	EP1724267A1 Pyrimidine derivative
11/22/2006	EP1723161A1 Radiolabeled compounds and compositions, their precursors and methods for their production
11/22/2006	EP1723149A1 Method of preparing thieno [3,2-c]pyridine derivatives and intermediates used therein
11/22/2006	EP1723148A2 Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors
11/22/2006	EP1723141A2 Industrial process for preparation of clopidogrel hydrogen sulphate
11/22/2006	EP1723122A2 Dimeric small molecule potentiators of apoptosis
11/22/2006	EP1722779A1 Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents
11/22/2006	EP1501798A4 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS
11/22/2006	EP1483271B1 Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1298132B1 Hydropyridine derivative acid addition salts
11/22/2006	EP1051176B1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/22/2006	CN1867566A Aminopyrones and their use as ATM inhibitors
11/22/2006	CN1867562A Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
11/22/2006	CN1865244A Synthesis method of imide substituted bridge ring compound
11/22/2006	CN1285597C 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
11/22/2006	CN1285595C Preparation process of thione
11/22/2006	CN1285594C Oxytocin agonists
11/21/2006	US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
11/21/2006	US7138529 e.g., N-(3-Cyano-4,5-dimethyl-thiophen-2-yl)-2,2-diphenyl-acetamide;3-Methyl-2-phenyl-pentanoic acid-(3-cyano-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl)-amide; or N-(3-Cyano-6-methanesulfonyl-4,5,6,7-tetrahydro-thieno [2,3-c]pyridin-2-yl)-2,2-diphenyl-acetamide;
11/21/2006	US7138409 Heterocyclic compounds
11/21/2006	US7138377 Substituted sugar derivatives of indolopyrrolocarbazoles, useful in inhibiting the proliferatin of tumor cells
11/21/2006	US7138075 Class of molecular actuators where bulk actuation mechanisms such as ion intercalation are enhanced by controllable single molecule conformational rearrangements offers promise in exhibiting large active strains at moderate stresses
11/20/2006	CA2611370A1 Inhibitors of vegf receptor and hgf receptor signaling
11/16/2006	WO2006122200A1 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilloid-1 receptor (vr1)
11/16/2006	WO2006121234A1 Biotin-amino acid conjugate useful as a hydrogelator and hydrogel prepared therefrom
11/16/2006	WO2006119975A1 Thienopyrroles as antiviral agents
11/16/2006	WO2006051397A3 Oligonucleotide probes
11/16/2006	US20060258737 Resistance-repellent retroviral protease inhibitors
11/16/2006	US20060258724 Anticoagulants; cardiovascular disorders; atherosclerosis; antiarthritic agents; Alzheimer's disease; anticancer agents
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258652 Beta-blockers having antioxidant and no-donor activity
11/16/2006	CA2607929A1 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilloid-1 receptor (vr1)
11/16/2006	CA2607421A1 Thienopyrroles as antiviral agents
11/15/2006	EP1720885A1 A process for making olanzapine in a polymorph form i
11/15/2006	EP1720884A1 Pharmacologically acceptable salts of clopidogrel
11/15/2006	EP1720855A1 Inhibitors of akt activity
11/15/2006	EP1427733B1 Thieno[2,3-d]pyrimidines with combined lh and fsh agonistic activity
11/15/2006	EP1401434B1 Modulators of peroxisome proliferator activated receptors (ppar)
11/15/2006	EP1323711B1 Novel phenylalanine derivatives
11/15/2006	CN1863890A New compound capable of being used in organic layer of organic light emitting device

1 ... 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... 214